Nitric oxide inhibits the expression of protein kinase C delta gene in the murine peritoneal macrophages. 1994

C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
Department of Microbiology and Immunology, School of Medicine, Wonkwang University, Iri, Chonbuk, Korea.

Since there is increasing evidence that protein kinase C (PKC) has a crucial role in the production of nitric oxide (NO) from activated macrophages, this study was undertaken to address whether NO could regulate the expression of the gene of this enzyme. Stimulation of the cells with lipopolysaccharide (LPS) or phorbol 12-myristate 13-acetate (PMA) after treatment with recombinant interferon-gamma (rIFN-gamma) resulted in the increased production of NO in the medium. rIFN-gamma in combination with either LPS or PMA showed marked inhibition of the expression of PKC delta gene, whereas rIFN-gamma alone showed modest inhibition. The inhibition of gene expression was correlated with the amount of NO produced by activated macrophages. The inhibitory effect of NO on the expression of PKC delta gene is mimicked by the treatment of NO generating agent, sodium nitroprusside (SNP). On the other hand, a specific inhibitor for NO synthase, NG-monomethyl-L-arginine (NGMMA), blocked the inhibition of the expression of PKC delta gene by blocking the NO production in the rIFN-gamma and LPS-stimulated cells. However, production of NO did not affect the expression of both TNF-alpha and TGF-beta gene which were induced by the stimulation of macrophages, as well as beta-actin gene, which was constitutively expressed in the macrophages. In conclusion, these findings show that NO has a regulatory role for the expression of the gene of PKC delta which is crucially involved in the process of NO synthesis.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC

Related Publications

C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
October 1999, Pharmacology & toxicology,
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
March 1996, Journal of leukocyte biology,
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
December 2000, Life sciences,
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
June 1993, Journal of immunology (Baltimore, Md. : 1950),
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
November 1992, Biochemical and biophysical research communications,
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
March 2000, International journal of immunopharmacology,
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
December 2001, Biochemical and biophysical research communications,
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
May 2002, Journal of immunology (Baltimore, Md. : 1950),
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
January 1990, Cancer communications,
C D Jun, and B M Choi, and S Y Lee, and S S Kang, and H M Kim, and H T Chung
March 1997, International journal of immunopharmacology,
Copied contents to your clipboard!